1-4 of 4
Israel Arango-Hisijara, MD
Close
Sort by
Journal Articles

Long-Term Follow-up of Ibrutinib Treatment for Rituximab-Refractory Waldenström's Macroglobulinemia: Final Analysis of the Open-Label Substudy of the Phase 3 iNNOVATE TM Trial

Judith Trotman, FRACP, Christian Buske, MD, Alessandra Tedeschi, MD, Jeffrey V. Matous, MD, David MacDonald, MD, Constantine Tam, MBBS, Olivier Tournilhac, MD PhD, Shuo Ma, MD PhD, Steven P. Treon, MD PhD, Albert Oriol, Jerry Ping, PhD, Eva M. Briso, PhD, Israel Arango-Hisijara, MD, Meletios A. Dimopoulos, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–39.
https://doi.org/10.1182/blood-2020-133916
Published: 2020
Journal Articles

Real-World Prognostic Biomarker Testing, Treatment Patterns and Dosing Among 1461 Patients (pts) with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) from the informCLL Prospective Observational Registry

Anthony R. Mato, MD, Jacqueline C. Barrientos, MD, Jeff P Sharman, MD, Danielle M. Brander, MD, Meghan Gutierrez, BA, Karen Kadish, MSN, Israel Arango-Hisijara, MD, Sandhya Upasani, Jennifer Han, PharmD, MBA, Qing Huang, PhD, Reethi Iyengar, PhD, Nilanjan Ghosh, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–43.
https://doi.org/10.1182/blood-2020-133798
Published: 2020
Journal Articles

Five-Year Follow-Up of Ibrutinib Plus Rituximab Vs Placebo Plus Rituximab for Waldenstrom's Macroglobulinemia: Final Analysis From the Randomized Phase 3 iNNOVATE TM Study

Christian Buske, MD, Alessandra Tedeschi, MD, Judith Trotman, MBChB, FRACP, FRCPA, Ramón García-Sanz, MD PhD, David MacDonald, MD, Veronique Leblond, MD PhD, Béatrice Mahé, MD, Charles Herbaux, MD, Jeffrey V. Matous, MD, Constantine S. Tam, MD, Leonard T. Heffner, MD, Marzia Varettoni, M. Lia Palomba, MD, Chaim Shustik, MD, Efstathios Kastritis, MD, Steven P. Treon, MD PhD, Jerry Ping, PhD, Bernhard Hauns, MD PhD, Israel Arango-Hisijara, MD, Meletios A Dimopoulos
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–26.
https://doi.org/10.1182/blood-2020-134460
Published: 2020
Journal Articles

Ibrutinib Therapy in Patients with Relapsed/Refractory Marginal Zone Lymphoma: Analysis By Prior Rituximab Treatment and Baseline Mutations

Robert Chen, MD, Sven de Vos, MD PhD, Catherine Thieblemont, MD PhD, Peter Martin, FRCPC, MD MS, Christopher Flowers, MD, Franck Morschhauser, MD PhD, Graham Collins, MD PhD, Shuo Ma, MD, Morton Coleman, MD, Shachar Peles, MD, Stephen D. Smith, MD, Jacqueline C. Barrientos, MD, Alina Smith, Brian Munneke, PhD, Shiquan Wu, PhD, Leo Cheung, PhD, Kevin Kwei, PhD, Selda Samakoglu, MD PhD, Israel Arango-Hisijara, MD, Isaiah Dimery, MD, Ariela Noy, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3026.
https://doi.org/10.1182/blood.V130.Suppl_1.3026.3026
Published: 2017